SCHEMBL12655970

SCHEMBL12655970

C=N/C=C(\NC1CCCN1C(=O)OC(C)(C)C)[Si](C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ NPC1 O15118 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ EPHX1 P07099 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SCN4A P35499 1/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ POLB P06746 2/20 0.36
▸ USP30 Q70CQ3 1/20 0.35
▸ RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12655486 0.83 NPC1 (0.41) ALDH1A1HSD17B10TSHRLMNANPSR1
SCHEMBL17948098 0.75 HSD17B10 (0.44) ALDH1A1HSD17B10TSHRLMNANPSR1
SCHEMBL28943307 0.75 HSD17B10 (0.51) ALDH1A1HSD17B10LMNANPSR1NPC1
SCHEMBL3940084 0.75 NPC1 (0.48) ALDH1A1HSD17B10TSHRLMNANPSR1
SCHEMBL9078128 0.75 HSD17B10 (0.48) ALDH1A1HSD17B10LMNANPSR1NPC1
SCHEMBL4244079 0.72 HSD17B10 (0.50) ALDH1A1HSD17B10LMNANPSR1NPC1
SCHEMBL2684345 0.72 HSD17B10 (0.50) ALDH1A1HSD17B10LMNANPSR1NPC1
SCHEMBL28232406 0.71 HSD17B10 (0.47) ALDH1A1HSD17B10LMNANPSR1NPC1
SCHEMBL12647717 0.71 HSD17B10 (0.40) ALDH1A1HSD17B10TSHRLMNANPSR1
SCHEMBL1319725 0.70 EPHX1 (0.47) ALDH1A1HSD17B10LMNANPSR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011060000-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 — — WO disclosed
Send feedback